Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

Melanoma is a disease characterized by lesions that activate ERK. Though 70% of cutaneous melanomas harbor activating mutations in the BRAF and NRAS genes, the alterations that drive tumor progression in the remaining 30% are largely undefined. Vemurafenib, a selective inhibitor of RAF kinases, has...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nissan, Moriah H., Pratilas, Christine A., Jones, Alexis M., Ramirez, Ricardo, Won, Helen, Liu, Cailian, Tiwari, Shakuntala, Kong, Li, Hanrahan, Aphrothiti J., Yao, Zhan, Merghoub, Taha, Ribas, Antoni, Chapman, Paul B., Yaeger, Rona, Taylor, Barry S., Schultz, Nikolaus, Berger, Michael F., Rosen, Neal, Solit, David B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4005042/
https://ncbi.nlm.nih.gov/pubmed/24576830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-2625
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados